Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 37 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 10537635

    Detection of arginine methylation of EGFR for prediction of resistance to therapy

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  2. US 10538762

    Allele selective inhibition of mutant C9orf72 foci expression by duplex RNAS targeting the expanded hexanucleotide repeat

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  3. US 10538579

    Bispecific pertussis antibodies

    The Board of Regents of the University of Texas System · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  4. US 10537553

    Methods of treating muscular dystrophy

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Jan 21, 2020 · Expires Jan 16, 2040

    granted

  5. US 10533227

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  6. US 10532109

    Peptide-DNA chimeras for treatment of HER overexpressing cancers

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  7. US 10531680

    Creatine ester pronutrient compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  8. US 10533186

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  9. US 10533997

    Reverse genetics system of Zika virus

    The Board of Regents of the University of Texas System · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  10. US 10526400

    Humanized pertussis antibodies and used thereof

    The Board of Regents of the University of Texas System · Granted Jan 7, 2020 · Expires Jan 2, 2040

    granted

  11. US 10517948

    Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  12. US 10519188

    Cyclic di-nucleotide compounds and methods of use

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  13. US 10519205

    Compositions and methods for use of anion channel rhodopsins

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  14. US 10519247

    Targeting HER2 and HER3 with bispecific antibodies in cancerous cells

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  15. US 10508129

    Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

    The Board of Regents of the University of Texas System · Granted Dec 17, 2019 · Expires Dec 12, 2039

    granted

  16. US 10501490

    Taccalonolide microtubule stabilizers

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  17. US 10501575

    Biomimetic fluoroscopic films

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  18. US 10501538

    Anti-LILRB antibodies and their use in detecting and treating cancer

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  19. US 10500256

    Polymers for delivery of therapeutic proteins

    The Board of Regents of the University of Texas System · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  20. US 10494619

    High isomerohydrolase activity mutants of human RPE65

    The Board of Regents of the University of Oklahoma · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  21. US 10493162

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  22. US 10493038

    Formulation of acoustically activatable particles having low vaporization energy and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 3, 2019 · Expires Nov 28, 2039

    granted

  23. US 10485800

    Mixed lineage kinase inhibitors for HIV/AIDS therapies

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  24. US 10485809

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.